Search for a trial

COVID-19: addition of azithromycin to chloroquine treatment

Primary objective:Does addition of azithromycin to standard chloroquine treatment result in a higher clinical cure rate at day 7 than treatment with chloroquine alone in patients with COVID-19.Cure is considered when 4 criteria are present:(1) O2…

The safety and cost-effectiveness of discontinuing disease-modifying therapies in stable relapsing-onset multiple sclerosis (DOT-MS): a randomized rater-blinded multicenter trial.

The aim of this study is to identify whether it is possible to safely discontinue treatment in stable RRMS patients who have shown no evidence of active inflammation in the years prior to inclusion in terms of the return of inflammatory disease…

Blood-borne assessment of stromal activation in esophageal
adenocarcinoma to guide tocilizumab therapy: a randomized
phase II proof-of-concept study

This study has been transitioned to CTIS with ID 2023-509458-77-00 check the CTIS register for the current data. The primary objective of the study of this study is to demonstrate that stroma-targeting by tocilizumab in esophageal adenocarcinoma…